The lawsuit also argues that Zepbound has been proven to be more effective for weight loss, and, on its formulary page for the switch, CVS acknowledges that studies with that implication exist while saying "real-world evidence suggests the two are comparable." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the plaintiffs said in their complaint
Adding Zofran may help reduce nausea, allowing more people to benefit from semaglutides weight loss effects
The Problems with Current GLP-1 Guidelines Traditional medicine waits to prescribe GLP-1 medications until a patients BMI hits 30 (obesity) or 27 with at least one weight-related health condition, such as high blood pressure or high cholesterol
Full text: Kumar, P., Osahon, O., Vides, D
Clinical trial data suggest that gastrointestinal side effects, including any reflux symptoms, typically improve over time as patients develop tolerance to the medication
